SCHEMBL2606549

SCHEMBL2606549

CC1(C)c2cc(C(=O)c3ccccc3)ccc2-c2ccc3c(c21)C(C)(C)c1cc(C(=O)c2ccccc2)c2ccccc2c1-3

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDK2 Q15119 1/20 0.43
▸ CNR2 P34972 2/20 0.41
▸ CYP2C8 P10632 1/20 0.40
▸ CYP2C9 P11712 1/20 0.40
▸ ATM Q13315 1/20 0.40
▸ TDP1 Q9NUW8 1/20 0.40
▸ L3MBTL1 Q9Y468 1/20 0.40
▸ RXRA P19793 3/20 0.36
▸ RARB P10826 2/20 0.36
▸ RARG P13631 2/20 0.36
▸ RXRB P28702 2/20 0.36
▸ RXRG P48443 2/20 0.36
▸ PBRM1 Q86U86 1/20 0.35
▸ PTPRC P08575 1/20 0.35
▸ MAPT P10636 2/20 0.35
▸ PTGS1 P23219 2/20 0.35
▸ CXCR1 P25024 2/20 0.35
▸ CXCR2 P25025 2/20 0.35
▸ PTGS2 P35354 2/20 0.35
▸ SMN1; SMN2 Q16637 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2606548 0.91 PDK2 (0.43) PDK2CNR2CYP2C8CYP2C9ATM
SCHEMBL12594529 0.88 CYP2C8 (0.43) PDK2CNR2CYP2C8CYP2C9ATM
SCHEMBL353237 0.83 CYP2C8 (0.40) CYP2C8CYP2C9ATMTDP1L3MBTL1
SCHEMBL12594543 0.82 CNR2 (0.41) PDK2CNR2CYP2C8CYP2C9ATM
SCHEMBL11914359 0.82 CNR2 (0.41) PDK2CNR2CYP2C8CYP2C9ATM
SCHEMBL16271526 0.76 PDK2 (0.52) PDK2CNR2ATMTDP1L3MBTL1
SCHEMBL25011572 0.75 PDK2 (0.62) PDK2CNR2CYP2C8CYP2C9ATM
SCHEMBL10227419 0.75 CYP2C8 (0.46) PDK2CNR2CYP2C8CYP2C9ATM
SCHEMBL11914299 0.74 PDK2 (0.39) PDK2CNR2CYP2C8CYP2C9RXRA
SCHEMBL14365749 0.74 CYP2C8 (0.35) CYP2C8CYP2C9RXRARARBRARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8241763-B2 Materials for organic electroluminescent devices MERCK PATENT GMBH (DE) 2012-08-14 — — US disclosed
US-8241763-B2 Materials for organic electroluminescent devices MERCK PATENT GMBH (DE) 2012-08-14 — — US disclosed
EP-2038370-B1 NOVEL MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2012-04-25 — — EP disclosed
US-20090261717-A1 NOVEL MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2009-10-22 — — US disclosed
US-20090261717-A1 NOVEL MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2009-10-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090261717-A1 NOVEL MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES L1CAM, SLC26A3, SLCO4C1 PDK2 2586/4885CNR2 3911/4885CYP2C8 3760/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback